Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2510]

Naproxen plus acid-blocking drug shows promise in preventing bladder cancer

Naproxen plus acid-blocking drug shows promise in preventing bladder cancer

Breast cancer risk may be increased in women who have first-degree relatives with a history of prostate cancer

Breast cancer risk may be increased in women who have first-degree relatives with a history of prostate cancer

Do healthy-looking prostate cancer cells mask deadly cancer-causing mutations?

Do healthy-looking prostate cancer cells mask deadly cancer-causing mutations?

ASCO GU: Early evidence of increase in higher-risk prostate cancers from 2011-2013

ASCO GU: Early evidence of increase in higher-risk prostate cancers from 2011-2013

ASCO GU: Active surveillance of intermediate-risk prostate cancer associated with decreased survival

ASCO GU: Active surveillance of intermediate-risk prostate cancer associated with decreased survival

ASCO GU: Adjuvant sorafenib and sunitinib do not improve outcomes in locally advanced kidney cancer

ASCO GU: Adjuvant sorafenib and sunitinib do not improve outcomes in locally advanced kidney cancer

ASCO GU: Androgen receptor abnormality may not be associated with primary resistance to taxane chemotherapy

ASCO GU: Androgen receptor abnormality may not be associated with primary resistance to taxane chemotherapy

ASCO GU: Men who have had testicular cancer are more likely to develop prostate cancer

ASCO GU: Men who have had testicular cancer are more likely to develop prostate cancer

Important milestone for mCRC patients as first liquid biopsy RAS biomarker testing centre opens

Important milestone for mCRC patients as first liquid biopsy RAS biomarker testing centre opens

Ninety percent of people in the UK approve of cancer screening but uptake is lower

Ninety percent of people in the UK approve of cancer screening but uptake is lower

More from ecancer